Key Market Indicators
Sales of Portuguese antacid medicine are expected to reach $6.2 million by 2026. This follows a 1.2% average annual decrease from $6.9 million in 2021. Since 2005, Portuguese market growth has averaged 3.3% each year. In 2021, Portugal ranked eighth, with Denmark just surpassing $6.9 million. Italy, Germany and Chile were the second, third, and fourth largest markets respectively.
